Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma. This evidence concerns the gene HIF1A and pancreatic ductal adenocarcinoma.